New approach designs healthcare robots with, not for, the people who use them

A new Cornell Tech-led study invites healthcare workers, long-term care residents, and community members to help design the robots themselves.

Around Cornell

Oral GLP-1 medication helps patients maintain weight loss

Switching to the oral small molecule glucagon-like peptide-1 (GLP-1) orforglipron after taking injectable GLP-1s helped patients maintain most of their weight loss, a clinical trial involving Weill Cornell Medicine has found.

New laws cut cannabis arrests, but racial disparities persist

While recreational cannabis laws have significantly reduced arrests for cannabis possession and sales, racial disparities in arrests still exist, according to a new study from Weill Cornell Medicine, Instituto Tecnológico Autónomo de México and the University of Texas at Austin.

A new kind of cold sensor

All life forms need to continuously adapt to temperature changes to survive. Now, Weill Cornell Medicine investigators studying a bacterial protein have identified a new mechanism of sensing cold temperatures.

Community Engagement Awards celebrate partnerships creating positive change

The fourth annual Community Engagement Awards celebrated community-engaged work by students, faculty and staff from across Cornell over the past year.

Around Cornell

Reverse engineering ketamine’s effects may lead to new antidepressants

Ketamine, an anesthetic, can provide immediate relief to some patients with treatment-resistant depression, but the effects are often short-lived.

T cells secrete DNA to help immune system fight cancer

Activated immune cells secrete tiny capsules bearing DNA that can enter other immune and tumor cells to stimulate the body’s defense systems, according to a study led by investigators at Weill Cornell Medicine.

Nerves in skin can slow melanoma growth

Researchers found that nerves of the sympathetic nervous system are often abundant in melanomas, and can inhibit tumor growth by reducing local tumor-supportive macrophages.

Discovery of immune tolerance switch could yield better IBD treatments

Weill Cornell Medicine investigators made an unexpected finding that could open new avenues for therapies against inflammatory bowel disease, food allergy and other autoimmune conditions.